Covered recipient · General Payments record
RAMESH K RAMANATHAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2023–2025
$9,013.52
- Reported across 165 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,054.99 | 45 |
| Education | $142.25 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $250.44 | 10 |
| Acerta Pharma LLC | $166.68 | 6 |
| SEAGEN INC. | $99.00 | 1 |
| Janssen Biotech, Inc. | $75.84 | 4 |
| Blueprint Medicines Corporation | $66.39 | 2 |
| ABBVIE INC. | $65.73 | 3 |
| Lilly USA, LLC | $58.52 | 2 |
| Incyte Corporation | $57.43 | 2 |
| TerSera Therapeutics LLC | $37.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.00 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.53 | 2 |
| Regeneron Healthcare Solutions, Inc. | $26.36 | 1 |
| Daiichi Sankyo Inc. | $25.64 | 1 |
| Rigel Pharmaceuticals, Inc. | $24.72 | 1 |
| EISAI INC. | $23.68 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.42 | 1 |
| Coherus Biosciences Inc. | $20.04 | 1 |
| Gilead Sciences, Inc. | $19.79 | 1 |
| Pharmacosmos Therapeutics Inc. | $18.96 | 1 |
| Novocure Inc. | $17.13 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.21 | 1 |
| Astellas Pharma US Inc | $16.01 | 1 |
| ARRAY BIOPHARMA INC | $15.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (47)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.